Emory Medical’s COVID-19 Antibody Test Authorized for Emergency Use

The FDA has granted an EUA for Emory Medical Laboratories’ SARS-CoV-2 receptor-binding domain (RBD) immunoglobulin G (IgG) test.

The enzyme-linked immunosorbent assay (ELISA) looks for the presence of immunoglobulin G, an antibody produced by the immune system when a virus attacks.

The test is only authorized for use at Emory University Hospital in Atlanta.